Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of AP214 Acetate in cardiac surgery patients
2008-006968-11Phase 2Completed
- Sponsor
- Action Pharma A/S
- Start
- Mar 2009
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, single-arm trial of modimelanotide in kidney failure and acute kidney failure (AKF), sponsored by Action Pharma A/S. Primary endpoints: Pharmacokinetics and Safety. Started Mar 2009; status: completed.
02
Drugs
modimelanotide
03
Conditions
kidney failureacute kidney failure (AKF)
Beyond the preview
Go deeper on 2008-006968-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006968-11.